JP2022527144A5 - - Google Patents
Info
- Publication number
- JP2022527144A5 JP2022527144A5 JP2021540477A JP2021540477A JP2022527144A5 JP 2022527144 A5 JP2022527144 A5 JP 2022527144A5 JP 2021540477 A JP2021540477 A JP 2021540477A JP 2021540477 A JP2021540477 A JP 2021540477A JP 2022527144 A5 JP2022527144 A5 JP 2022527144A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- car according
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025126649A JP2025172739A (ja) | 2019-01-11 | 2025-07-29 | 抗可変muc1*抗体およびその使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962791661P | 2019-01-11 | 2019-01-11 | |
| US62/791,661 | 2019-01-11 | ||
| PCT/US2019/019566 WO2019165421A1 (en) | 2018-02-26 | 2019-02-26 | Diagnostic methods using anti-muc1* antibodies |
| USPCT/US2019/019566 | 2019-02-26 | ||
| USPCT/US2019/021556 | 2019-03-11 | ||
| PCT/US2019/021556 WO2019173815A2 (en) | 2018-03-09 | 2019-03-11 | Method for anti-muc1* car t cell stimulation |
| PCT/US2020/013410 WO2020146902A2 (en) | 2019-01-11 | 2020-01-13 | Anti-variable muc1* antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025126649A Division JP2025172739A (ja) | 2019-01-11 | 2025-07-29 | 抗可変muc1*抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527144A JP2022527144A (ja) | 2022-05-31 |
| JP2022527144A5 true JP2022527144A5 (cg-RX-API-DMAC7.html) | 2023-04-18 |
Family
ID=71521210
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540477A Pending JP2022527144A (ja) | 2019-01-11 | 2020-01-13 | 抗可変muc1*抗体およびその使用 |
| JP2025126649A Pending JP2025172739A (ja) | 2019-01-11 | 2025-07-29 | 抗可変muc1*抗体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025126649A Pending JP2025172739A (ja) | 2019-01-11 | 2025-07-29 | 抗可変muc1*抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12583927B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3908603A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022527144A (cg-RX-API-DMAC7.html) |
| CN (2) | CN120484122A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020205735A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3126391A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL284772A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020146902A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3256494A4 (en) | 2015-02-10 | 2018-12-05 | Minerva Biotechnologies Corporation | Humanized anti-muc1* antibodies |
| WO2019165421A1 (en) * | 2018-02-26 | 2019-08-29 | Minerva Biotechnologies Corporation | Diagnostic methods using anti-muc1* antibodies |
| WO2020146902A2 (en) | 2019-01-11 | 2020-07-16 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
| CA3183682A1 (en) | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| CN116234828A (zh) * | 2020-07-29 | 2023-06-06 | 米纳瓦生物技术公司 | 抗可变muc1*抗体及其用途 |
| EP4210733B1 (en) * | 2020-09-04 | 2024-11-06 | Miltenyi Biotec B.V. & Co. KG | System for inducible expression of an adapter in immune cells |
| IL312606A (en) * | 2021-11-09 | 2024-07-01 | Janssen Biotech Inc | Microfluidic co-encapsulation device and system and methods for identifying t-cell receptor ligands |
| WO2023123195A1 (zh) * | 2021-12-30 | 2023-07-06 | 深圳市先康达生命科学有限公司 | 一种目的基因可调控的工程化免疫细胞及其制备方法和应用 |
| CA3248038A1 (en) * | 2022-04-12 | 2023-10-19 | Minerva Biotechnologies Corporation | ANTI-MUC1* VARIABLE ANTIBODIES AND RELATED USES |
| IL316918A (en) * | 2022-05-09 | 2025-01-01 | Minerva Biotechnologies Corp | Chimeric antigen receptor and IL-18 receptor compositions and methods of using them |
| US20240261406A1 (en) | 2023-02-02 | 2024-08-08 | Minerva Biotechnologies Corporation | Chimeric antigen receptor compositions and methods for treating muc1* diseases |
| EP4587063A1 (en) * | 2023-10-11 | 2025-07-23 | Minerva Biotechnologies Corporation | Anti-muc1* antibody drug complexes and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240390418A1 (en) | 1997-09-04 | 2024-11-28 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
| EP1290217A2 (en) * | 2000-02-04 | 2003-03-12 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| AU2002368077B2 (en) | 2001-07-12 | 2010-03-04 | Jefferson Foote | Super humanized antibodies |
| GB0802931D0 (en) * | 2008-02-18 | 2008-03-26 | Queen Mary & Westfield College | Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions |
| JP2012504961A (ja) | 2008-10-06 | 2012-03-01 | ミネルバ バイオテクノロジーズ コーポレーション | Muc1*抗体 |
| JP2012034668A (ja) * | 2010-08-12 | 2012-02-23 | Tohoku Univ | ヒト型化抗egfr抗体リジン置換可変領域断片及びその利用 |
| AU2013302620B2 (en) * | 2012-08-14 | 2018-08-02 | Minerva Biotechnologies Corporation | Stem cell enhancing therapeutics |
| CN106132992B (zh) | 2014-01-29 | 2020-08-07 | 达娜-法勃肿瘤研究所公司 | 针对muc1-c/胞外结构域(muc1-c/ecd)的抗体 |
| EP4050103A1 (en) | 2014-04-07 | 2022-08-31 | Minerva Biotechnologies Corporation | Anti-nme antibody |
| EP3256494A4 (en) * | 2015-02-10 | 2018-12-05 | Minerva Biotechnologies Corporation | Humanized anti-muc1* antibodies |
| AU2016229189A1 (en) * | 2015-03-06 | 2017-09-21 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind TIM3 |
| CA3039797A1 (en) * | 2016-10-11 | 2018-04-19 | Minerva Biotechnologies Corporation | Humanized anti-muc1* antibodies and use of cleavage enzyme |
| US11578115B2 (en) * | 2017-01-10 | 2023-02-14 | The General Hospital Corporation | Chimeric antigen receptors based on alternative signal 1 domains |
| WO2019104306A1 (en) | 2017-11-27 | 2019-05-31 | Minerva Biotechnologies Corporation | Humanized anti-muc1* antibodies and direct use of cleavage enzyme |
| MX428412B (es) | 2017-12-24 | 2025-11-13 | Noile Immune Biotech Inc | Celula inmunocompetente que expresa una molecula de superficie celular que reconoce especificamente la mesotelina humana, il-7 y ccl19 |
| IL326873A (en) | 2017-12-29 | 2026-04-01 | Memorial Sloan Kettering Cancer Center | Enhanced chimeric antigen receptors and uses thereof |
| WO2019165421A1 (en) * | 2018-02-26 | 2019-08-29 | Minerva Biotechnologies Corporation | Diagnostic methods using anti-muc1* antibodies |
| EP3868783A4 (en) | 2018-10-19 | 2022-01-19 | Cartexell Inc. | ANTI-L1CAM ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND CHIMERIC ANTIGEN RECEPTOR THEREOF |
| WO2020116686A1 (ko) | 2018-12-06 | 2020-06-11 | 고려대학교 산학협력단 | 인간 항-antxr 키메라 항원 수용체 및 이의 용도 |
| WO2020146902A2 (en) | 2019-01-11 | 2020-07-16 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
| CN110903401A (zh) | 2019-11-20 | 2020-03-24 | 浙江大学 | 一种靶向cd19的二代嵌合抗原受体及其表达载体与应用 |
| CN116234828A (zh) | 2020-07-29 | 2023-06-06 | 米纳瓦生物技术公司 | 抗可变muc1*抗体及其用途 |
| US20240261406A1 (en) | 2023-02-02 | 2024-08-08 | Minerva Biotechnologies Corporation | Chimeric antigen receptor compositions and methods for treating muc1* diseases |
-
2020
- 2020-01-13 WO PCT/US2020/013410 patent/WO2020146902A2/en not_active Ceased
- 2020-01-13 CA CA3126391A patent/CA3126391A1/en active Pending
- 2020-01-13 AU AU2020205735A patent/AU2020205735A1/en active Pending
- 2020-01-13 JP JP2021540477A patent/JP2022527144A/ja active Pending
- 2020-01-13 EP EP20738367.0A patent/EP3908603A4/en active Pending
- 2020-01-13 CN CN202510558379.6A patent/CN120484122A/zh active Pending
- 2020-01-13 CN CN202080020073.0A patent/CN113853386A/zh active Pending
-
2021
- 2021-07-11 IL IL284772A patent/IL284772A/en unknown
- 2021-07-12 US US17/373,609 patent/US12583927B2/en active Active
-
2025
- 2025-07-29 JP JP2025126649A patent/JP2025172739A/ja active Pending